Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 372,507 shares of the company's stock after selling 12,337 shares during the period. Bank of New York Mellon Corp owned 0.75% of Prestige Consumer Healthcare worth $32,024,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Franklin Resources Inc. increased its stake in Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock worth $1,697,000 after purchasing an additional 150 shares during the period. KBC Group NV increased its stake in Prestige Consumer Healthcare by 7.4% during the first quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after purchasing an additional 151 shares during the period. CIBC Private Wealth Group LLC increased its stake in Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after purchasing an additional 152 shares during the period. McIlrath & Eck LLC increased its stake in Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after purchasing an additional 154 shares during the period. Finally, O Shaughnessy Asset Management LLC increased its stake in Prestige Consumer Healthcare by 3.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after purchasing an additional 207 shares during the period. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded up $0.57 during trading hours on Friday, hitting $75.70. The company's stock had a trading volume of 419,148 shares, compared to its average volume of 316,403. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20. The company has a market capitalization of $3.74 billion, a PE ratio of 17.65, a PEG ratio of 2.25 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 52-week low of $64.94 and a 52-week high of $90.04. The business's 50-day moving average is $82.92 and its two-hundred day moving average is $82.26.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The firm had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. During the same period last year, the company earned $1.02 EPS. The firm's quarterly revenue was up 7.0% on a year-over-year basis. As a group, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on PBH shares. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.